PLRX: Raben David discloses securities transactions

By AlphaYouPublished Oct 2, 2026Form 4

Stocks in this disclosure

Reported activity

Raben David

Reporting filer

Raben David reported Grant or award in PLIANT THERAPEUTICS, INC.: 575000 units of Stock Option (Right to Buy) (derivative), dated 2026-10-01. The full Form 4 contains 1 transaction entry.

Disclosed: Oct 2, 2026

Reported details

1 entry

All validated entries in this disclosure
Security	Owner	Date	Code	Action	Quantity	Price	Following holdings	Reporting delay	Filed terms and references
Stock Option (Right to Buy) (derivative)	Raben David	2026-10-01	A	Grant or award	575000	0	575,000	1 day	Filed terms security Title: Stock Option (Right to Buy) conversion Or Exercise Price: 1.05 transaction Date: 2026-10-01 transaction Form Type: 4 transaction Code: A equity Swap Involved: 0 transaction Shares: 575000 transaction Price Per Share: 0 transaction Acquired Disposed Code: A id: F1 expiration Date: 2036-10-01 underlying Security Title: Common Stock underlying Security Shares: 575000 shares Owned Following Transaction: 575000 direct Or Indirect Ownership: D

Stock Option (Right to Buy) (derivative)

Owner: Raben David
Date: 2026-10-01
Code: A
Action: Grant or award
Quantity: 575000
Price: 0
Following holdings: 575,000
Reporting delay: 1 day
Filed terms and references: Filed terms
security Title: Stock Option (Right to Buy)
conversion Or Exercise Price: 1.05
transaction Date: 2026-10-01
transaction Form Type: 4
transaction Code: A
equity Swap Involved: 0
transaction Shares: 575000
transaction Price Per Share: 0
transaction Acquired Disposed Code: A
id: F1
expiration Date: 2036-10-01
underlying Security Title: Common Stock
underlying Security Shares: 575000
shares Owned Following Transaction: 575000
direct Or Indirect Ownership: D

Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.

Filing context

Quantities and prices are shown in the units filed. No trade value is inferred from their product.
Raben David: Chief Medical Officer.
F1: Twenty-five percent (25%) of the shares subject to such option vest and become exercisable on September 30, 2027, and the remaining seventy-five percent (75%) of the shares subject to the option vest and become exercisable in substantially equal installments thereafter on each monthly anniversary of September 30, 2027 (or if there is no corresponding day in any such month, on the last day of each month) over three (3) years, subject to the Reporting Person's continuous service to the Issuer on each such date.

Original sources

SEC ownership filing

Prepared automatically from public filing data. Report a correction.

Security

Owner

Date

Code

Action

Quantity

Price

Following holdings

Reporting delay

Filed terms and references

Stock Option (Right to Buy) (derivative)

Raben David

2026-10-01

Grant or award

575000

575,000

1 day

Filed terms

security Title: Stock Option (Right to Buy)
conversion Or Exercise Price: 1.05
transaction Date: 2026-10-01
transaction Form Type: 4
transaction Code: A
equity Swap Involved: 0
transaction Shares: 575000
transaction Price Per Share: 0
transaction Acquired Disposed Code: A
id: F1
expiration Date: 2036-10-01
underlying Security Title: Common Stock
underlying Security Shares: 575000
shares Owned Following Transaction: 575000
direct Or Indirect Ownership: D

Filing context

Quantities and prices are shown in the units filed. No trade value is inferred from their product.

Raben David: Chief Medical Officer.

F1: Twenty-five percent (25%) of the shares subject to such option vest and become exercisable on September 30, 2027, and the remaining seventy-five percent (75%) of the shares subject to the option vest and become exercisable in substantially equal installments thereafter on each monthly anniversary of September 30, 2027 (or if there is no corresponding day in any such month, on the last day of each month) over three (3) years, subject to the Reporting Person's continuous service to the Issuer on each such date.